The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics

Reviews in Medical Virology

Volumn 26, Issue 4, 2016, Pages 285-303

  Kramvis, Anna ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

GENE MUTATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HELPER CELL; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE A; HEPATITIS B VIRUS GENOTYPE B; HEPATITIS B VIRUS GENOTYPE C; HEPATITIS B VIRUS GENOTYPE D; HEPATITIS B VIRUS GENOTYPE F; HEPATITIS B VIRUS GENOTYPE H; HEPATITIS B VIRUS GENOTYPE I; HUMAN; MOLECULAR BIOLOGY; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; VIRUS REPLICATION;

EID: 84978865139     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1885     Document Type: Review

References (153)

1. Hepatitis B Fact sheet no 204. http://www.who.int/mediacentre/factsheets/fs204/en/ [October 2015].
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095–2128. DOI:10.1016/S0140-6736(12)61728-0.
3. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 2212–2219. DOI:10.1016/j.vaccine.2011.12.116 S0264-410X(11)02077-9 [pii].
4. Komatsu H, Inui A. Hepatitis B virus infection in children. Expert Review of Anti-Infective Therapy 2015; 13: 427–450. DOI:10.1586/14787210.2015.1019867.
5. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489–495.
6. Summers J, Mason WS. Replication of the genome of a hepatitis B—like virus by reverse transcription of an RNA intermediate. Cell 1982; 29: 403–415.
7. Beck J, Nassal M. Hepatitis B virus replication. World Journal of Gastroenterology 2007; 13: 48–64.
8. Junker-Niepmann M, Bartenschlager R, Schaller H. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO Journal 1990; 9: 3389–3396.
9. Kramvis A, Kew MC. Structure and function of the encapsidation signal of hepadnaviridae. Journal of Viral Hepatitis 1998; 5: 357–367.
10. Magnius LO, Espmark A. A new antigen complex co-occurring with Australia antigen. Acta Pathologica et Microbiologica Scandinavica. Section B: Microbiology and Immunology 1972; 80: 335–337.
11. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine 2005; 23: 2409–2423. DOI:10.1016/j.vaccine.2004.10.045 S0264-410X(04)00849-7.
12. Yuh CH, Chang YL, Ting LP. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. Journal of Virology 1992; 66: 4073–4084.
13. Yu X, Mertz JE. Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. Journal of Virology 1996; 70: 8719–8726.
14. Kramvis A, Kew MC. The core promoter of hepatitis B virus. Journal of Viral Hepatitis 1999; 6: 415–427. DOI:10.1046/j.1365-2893.1999.00189.x jvh189 [pii].
15. Ou JH, Laub O, Rutter WJ. Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proceedings of the National Academy of Sciences of the United States of America 1986; 83: 1578–1582.
16. Jean-Jean O, Levrero M, Will H, Perricaudet M, Rossignol JM. Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. Virology 1989; 170: 99–106.
17. Revill P, Yuen L, Walsh R, Perrault M, Locarnini S, Kramvis A. Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses. Journal of Medical Virology 2010; 82: 104–115. DOI:10.1002/jmv.21645.
18. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003; 38: 1075–1086. DOI:10.1053/jhep.2003.50453 S027091390300836X [pii].
19. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Annals of Internal Medicine 1981; 94: 744–748.
20. Chen M, Sallberg M, Hughes J, et al. Immune tolerance split between hepatitis B virus precore and core proteins. Journal of Virology 2005; 79: 3016–3027. DOI:10.1128/JVI.79.5.3016-3027.2005 79/5/3016 [pii].
21. Chen MT, Billaud JN, Sallberg M, et al. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 14913–14918. DOI:10.1073/pnas.0406282101 0406282101 [pii].
22. Yang CY, Kuo TH, Ting LP. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. Journal of Biological Chemistry 2006; 281: 34525–34536. DOI:10.1074/jbc.M510981200 M510981200 [pii].
23. Visvanathan K, Skinner NA, Thompson AJ, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45: 102–110. DOI:10.1002/hep.21482.
24. Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. Journal of Pediatrics 1987; 111: 34–39.
25. Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. Journal of Hepatology 2011; 55: 183–191. DOI:10.1016/j.jhep.2010.12.030 S0168-8278(11)00023-7 [pii].
26. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. Journal of Pediatrics 1998; 133: 374–377. DOI:10.1016/S0022-3476(98)70272-0.
27. Ni YH. Natural history of hepatitis B virus infection: pediatric perspective. Journal of Gastroenterology 2011; 46: 1–8. DOI:10.1007/s00535-010-0304-7.
28. Choe HJ, Choe BH. What physicians should know about the management of chronic hepatitis B in children: East side story. World Journal of Gastroenterology 2014; 20: 3582–3589. DOI:10.3748/wjg.v20.i13.3582.
29. Hsu HY, Chang MH, Hsieh KH, et al. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology 1992; 15: 770–776 DOI: 10.1002/hep.1840150505.
30. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507–539. DOI:10.1002/hep.21513.
31. Gish RG, Given BD, Lai CL, et al. Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities. Antiviral Research 2015; 121: 47–58. DOI:10.1016/j.antiviral.2015.06.008.
32. Ni YH, Chang MH, Chen PJ, et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. Gastroenterology 2007; 132: 2340–2345. DOI:10.1053/j.gastro.2007.03.111 S0016-5085(07)00637-3 [pii].
33. Chang MH, Hwang LY, Hsu HC, Lee CY, Beasley RP. Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology 1988; 8: 374–377 S0270913988000576 [pii].
34. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006; 43: S173–181. DOI:10.1002/hep.20956.
35. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582–592. DOI:10.1016/S0140-6736(09)60207-5 S0140-6736(09)60207-5 [pii].
36. Bortolotti F, Cadrobbi P, Crivellaro C, et al. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990; 99: 805–810 S0016508590003213 [pii].
37. Marx G, Martin SR, Chicoine JF, Alvarez F. Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins. Journal of Infectious Diseases 2002; 186: 295–301. DOI:10.1086/341508 JID011277 [pii].
38. Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 1995; 22: 1387–1392 S0270913995003855 [pii].
39. Iorio R, Giannattasio A, Cirillo F, D' Alessandro L, Vegnente A. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Clinical Infectious Diseases 2007; 45: 943–949. DOI:10.1086/521864 CID51006 [pii].
40. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatology Research 2007; 37: S9–S19. DOI:10.1111/j.1872-034X.2007.00098.x HEP098 [pii].
41. Malamitsi-Puchner A, Papacharitonos S, Sotos D, et al. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. European Journal of Epidemiology 1996; 12: 297–301.
42. Ni YH, Huang LM, Chang MH, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007; 132: 1287–1293. DOI:10.1053/j.gastro.2007.02.055 S0016-5085(07)00414-3 [pii].
43. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. Journal of Medical Virology 2004; 72: 363–369. DOI:10.1002/jmv.10534.
44. Wen WH, Chang MH, Hsu HY, Ni YH, Chen HL. The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection. Journal of Pediatrics 2004; 144: 397–399. DOI:10.1016/j.jpeds.2003.11.022 S0022-3476(03)00855-2 [pii].
45. Pollicino T, Raimondo G. Occult hepatitis B infection. Journal of Hepatology 2014; 61: 688–689. DOI:10.1016/j.jhep.2014.04.036.
46. Chang MH. Natural history and clinical management of chronic hepatitis B virus infection in children. Hepatology International 2008; 2: 28–36. DOI:10.1007/s12072-008-9050-9.
47. Lok AS, Lai CL. A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology 1988; 8: 1130–1133 DOI: 10.1002/hep.1840150304.
48. Hsu HY, Chang MH, Lee CY, Chen JS, Hsu HC, Chen DS. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection. Hepatology 1992; 15: 382–386 DOI: 10.1002/hep.1840150304.
49. Boxall EH, Sira J, Standish RA, et al. Natural history of hepatitis B in perinatally infected carriers. Archives of Disease in Childhood—Fetal and Neonatal Edition 2004; 89: F456–460. DOI:10.1136/adc.2002.009837 89/5/F456 [pii].
50. Bortolotti F, Jara P, Crivellaro C, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. Journal of Hepatology 1998; 29: 184–190. DOI:10.1016/S0168-8278(98)80002-0.
51. Chang MH, Chen PJ, Chen JY, et al. Hepatitis B virus integration in hepatitis B virus-related hepatocellular carcinoma in childhood. Hepatology 1991; 13: 316–320 DOI: 10.1002/hep.1840130218.
52. Kramvis A, Kew MC. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. Journal of Viral Hepatitis 2005; 12: 456–464. DOI:10.1111/j.1365-2893.2005.00624.x JVH624 [pii].
53. Yu H, Yuan Q, Ge SX, et al. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype “I”. PloS One 2010; 5: e9297. DOI:10.1371/journal.pone.0009297.
54. Norder H, Courouce AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289–309. DOI:10.1159/000080872 INT2004047006289 [pii].
55. Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology 2014; 57: 141–150. DOI:10.1159/000360947 000360947 [pii].
56. Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. Journal of Virology 2009; 83: 10538–10547. DOI:10.1128/JVI.00462-09 JVI.00462-09 [pii].
57. Locarnini S, Littlejohn M, Aziz MN, Yuen L. Possible origins and evolution of the hepatitis B virus (HBV). Seminars in Cancer Biology 2013; 23: 561–575. DOI:10.1016/j.semcancer.2013.08.006 S1044-579X(13)00082-5 [pii].
58. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO, Kew MC. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. Journal of Medical Virology 2008; 80: 27–46. DOI:10.1002/jmv.21049.
59. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. Journal of Gastroenterology and Hepatology 2002; 17: 643–650 DOI: 10.1046/j.1440-1746.2002.02737.x.
60. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatology International 2009; 3: 334–342. DOI:10.1007/s12072-008-9112-z.
61. Yousif M, Kramvis A. Genotype D of hepatitis B virus and its subgenotypes: an update. Hepatology Research 2013; 43: 355–364. DOI:10.1111/j.1872-034X.2012.01090.x.
62. Kramvis A, Paraskevis D. Subgenotype A1 of HBV—tracing human migrations in and out of Africa. Antiviral Therapy 2013; 18: 513–521. DOI:10.3851/IMP2657.
63. Owiredu WK, Kramvis A, Kew MC. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D. Journal of Medical Virology 2001; 64: 441–454.
64. Bowyer SM, Sim JG. Relationships within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates. The Journal of General Virology 2000; 81: 379–392.
65. Sugauchi F, Orito E, Ichida T, et al. Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene. Journal of Virology 2002; 76: 5985–5992.
66. Cui C, Shi J, Hui L, et al. The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid. The Journal of General Virology 2002; 83: 2773–2777.
67. Simmonds P, Midgley S. Recombination in the genesis and evolution of hepatitis B virus genotypes. Journal of Virology 2005; 79: 15467–15476. DOI:10.1128/JVI.79.24.15467-15476.2005.
68. Shi W, Carr MJ, Dunford L, Zhu C, Hall WW, Higgins DG. Identification of novel inter-genotypic recombinants of human hepatitis B viruses by large-scale phylogenetic analysis. Virology 2012; 427: 51–59. DOI:10.1016/j.virol.2012.01.030 S0042-6822(12)00077-3 [pii].
69. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY. Molecular evolution of hepatitis B virus over 25 years. Journal of Virology 2006; 80: 10307–10314. DOI:10.1128/JVI.00996-06 80/21/10307 [pii].
70. Hu X, Margolis HS, Purcell RH, Ebert J, Robertson BH. Identification of hepatitis B virus indigenous to chimpanzees. Proceedings of the National Academy of Sciences of the United States of America 2000; 97: 1661–1664 DOI: 10.1073/pnas.97.4.1661.
71. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994; 198: 489–503. DOI:10.1006/viro.1994.1060 S0042-6822(84)71060-9 [pii].
72. Bartholomeusz A, Schaefer S. Hepatitis B virus genotypes: comparison of genotyping methods. Reviews in Medical Virology 2004; 14: 3–16.
73. Guirgis BS, Abbas RO, Azzazy HM. Hepatitis B virus genotyping: current methods and clinical implications. International Journal of Infectious Diseases 2010; 14: e941–953. DOI:10.1016/j.ijid.2010.03.020.
74. Bell TG, Kramvis A. The study of hepatitis B virus using bioinformatics. In Bioinformatics, Abdurakhmanov IY (ed). InTech—Open Access Publisher, 2016. DOI: 10.5772/63076 Available from:http://www.intechopen.com/
75. Chu CM, Yeh CT, Sheen IS, Liaw YF. Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B. Gastroenterology 1995; 109: 1926–1932. DOI:10.1016/0016-5085(95)90760-2.
76. Chu CM, Yeh CT, Lee CS, Sheen IS, Liaw YF. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. Journal of Clinical Microbiology 2002; 40: 16–21.
77. Yuen MF, Sablon E, Yuan HJ, et al. Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. Journal of Infectious Diseases 2002; 186: 1335–1338. DOI:10.1086/344327 JID020471 [pii].
78. Buckwold VE, Xu Z, Chen M, Yen TS, Ou JH. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. Journal of Virology 1996; 70: 5845–5851.
79. Ahn SH, Kramvis A, Kawai S, et al. Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production. Gastroenterology 2003; 125: 1370–1378 DOI: 10.1016/j.gastro.2003.07.016.
80. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588–591. DOI:10.1016/S0140-6736(89)90713-7.
81. Chen CY, Crowther C, Kew MC, Kramvis A. A valine to phenylalanine mutation in the precore region of hepatitis B virus causes intracellular retention and impaired secretion of HBe-antigen. Hepatology Research 2008; 38: 580–592. DOI:10.1111/j.1872-034X.2007.00315.x HEP315 [pii].
82. Bell TG, Kramvis A. Mutation Reporter Tool: an online tool to interrogate loci of interest, with its utility demonstrated using hepatitis B virus. Virology Journal 2013; 10: 62. DOI:10.1186/1743-422X-10-62 1743-422X-10-62 [pii].
83. Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. Journal of Virology 1993; 67: 5402–5410.
84. Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 4077–4081.
85. Kramvis A, Kew MC. Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus. Hepatology Research 2007; 37: S27–32. DOI:10.1111/j.1872-034X.2007.00100.x HEP100 [pii].
86. Tanaka Y, Hasegawa I, Kato T, et al. A case–control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology 2004; 40: 747–755. DOI:10.1002/hep.20365.
87. Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122: 1756–1762 DOI: 10.1053/gast.2002.33588.
88. Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology 2007; 133: 1452–1457. DOI:10.1053/j.gastro.2007.08.010 S0016-5085(07)01456-4 [pii].
89. Candotti D, Opare-Sem O, Rezvan H, Sarkodie F, Allain JP. Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase. Journal of Viral Hepatitis 2006; 13: 715–724. DOI:10.1111/j.1365-2893.2006.00741.x JVH741 [pii].
90. Kao JH, Chen PJ, Lai MY, Chen DS. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. Journal of Clinical Microbiology 2002; 40: 22–25.
91. Ott JJ, Stevens GA, Wiersma ST. The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infectious Diseases 2012; 12: 131. DOI:10.1186/1471-2334-12-131.
92. Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. British Journal of Obstetrics and Gynaecology 1980; 87: 958–965.
93. Pournik O, Alavian SM, Ghalichi L, Hajibeigi B, Razavi AR, Eslami S. Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis d coinfection: a data-mining approach. Hepatitis Monthly 2013; 13: e7652. DOI:10.5812/hepatmon.7652.
94. Madejon A, Romero M, Hernandez A, et al. Hepatitis B and D viruses replication interference: influence of hepatitis B genotype. World Journal of Gastroenterology 2016; 22: 3165–3174. DOI:10.3748/wjg.v22.i11.3165.
95. Ohto H, Lin HH, Kawana T, Etoh T, Tohyama H. Intrauterine transmission of hepatitis B virus is closely related to placental leakage. Journal of Medical Virology 1987; 21: 1–6.
96. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case–control study. Journal of Medical Virology 2002; 67: 20–26.
97. Bai H, Zhang L, Ma L, Dou XG, Feng GH, Zhao GZ. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World Journal of Gastroenterology 2007; 13: 3625–3630.
98. Li XM, Shi MF, Yang YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World Journal of Gastroenterology 2004; 10: 3215–3217.
99. Cacciola I, Cerenzia G, Pollicino T, et al. Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. Journal of Hepatology 2002; 36: 426–432 DOI: 10.1016/S0168-8278(01)00295-1.
100. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver International 2009; 29(Suppl 1): 133–139. DOI:10.1111/j.1478-3231.2008.01933.x.
101. Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. Journal of Infectious Diseases 1983; 147: 185–190.
102. Lee AK, Ip HM, Wong VC. Mechanisms of maternal–fetal transmission of hepatitis B virus. Journal of Infectious Diseases 1978; 138: 668–671.
103. Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. American Journal of Obstetrics and Gynecology 2001; 184: 1514–1518 discussion 1518-1520.
104. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. New England Journal of Medicine 1976; 294: 746–749. DOI:10.1056/NEJM197604012941402.
105. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. American Journal of Epidemiology 1977; 105: 94–98.
106. Beasley RP, Hwang LY, Lin CC, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet 1981; 2: 388–393. DOI:10.1016/S0140-6736(81)90832-1.
107. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. New England Journal of Medicine 1975; 292: 771–774.
108. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. Journal of Medical Virology 1979; 3: 237–241.
109. Tong MJ, Thursby MW, Lin JH, Weissman JY, McPeak CM. Studies on the maternal–infant transmission of the hepatitis B virus and HBV infection within families. Progress in Medical Virology 1981; 27: 137–147.
110. Pongpipat D, Suvatte V, Assateerawatts A. Perinatal transmission of hepatitis B virus in Thailand. Asian Pacific Journal of Allergy and Immunology 1985; 3: 191–193.
111. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiology and Infection 1996; 117: 313–325.
112. Karayiannis P, Novick DM, Lok AS, Fowler MJ, Monjardino J, Thomas HC. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. British Medical Journal (Clinical Research Ed.) 1985; 290: 1853–1855.
113. Martinson FE, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. American Journal of Epidemiology 1998; 147: 478–487.
114. Jombo GT, Egah DZ, Banwat EB. Hepatitis B virus infection in a rural settlement of northern Nigeria. Nigerian Journal of Medicine 2005; 14: 425–428.
115. Otegbayo JA, Fasola FA, Abja A. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Tropical Gastroenterology 2003; 24: 196–197.
116. Ghendon Y. Perinatal transmission of hepatitis B virus in high-incidence countries. Journal of Virological Methods 1987; 17: 69–79. DOI:10.1016/0166-0934(87)90070-X.
117. Hsu SC, Chang MH, Ni YH, Hsu HY, Lee CY. Horizontal transmission of hepatitis B virus in children. Journal of Pediatric Gastroenterology and Nutrition 1993; 16: 66–69.
118. Dumpis U, Holmes EC, Mendy M, et al. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. Journal of Hepatology 2001; 35: 99–104 S0168827801000642 [pii].
119. Whittle HC, Bradley AK, McLauchlan K, et al. Hepatitis B virus infection in two Gambian villages. Lancet 1983; 1: 1203–1206.
120. Burnett RJ, Francois G, Kew MC, et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver International 2005; 25: 201–213. DOI:10.1111/j.1478-3231.2005.01054.x LIV1054 [pii].
121. Jacobs B, Mayaud P, Changalucha J, et al. Sexual transmission of hepatitis B in Mwanza, Tanzania. Sexually Transmitted Diseases 1997; 24: 121–126.
122. Rosendahl C, Kochen MM, Kretschmer R, Wegscheider K, Kaiser D. Avoidance of perinatal transmission of hepatitis B virus: is passive immunisation always necessary? Lancet 1983; 1: 1127–1129. DOI:10.1016/S0140-6736(83)92866-0.
123. Chan SH, Tan KL, Goh KT, et al. Maternal–child hepatitis B virus transmission in Singapore. International Journal of Epidemiology 1985; 14: 173–177.
124. Tan DS, Zaini Rahman M, Fang R, Collett D, Ooi BG. Hepatitis B markers in non-icteric medical patients in Malaysia. Southeast Asian Journal of Tropical Medicine and Public Health 1986; 17: 214–218.
125. Zhang SL, Han XB, Yue YF. Relationship between HBV viremia level of pregnant women and intrauterine infection: neated PCR for detection of HBV DNA. World Journal of Gastroenterology 1998; 4: 61–63.
126. Derso A, Boxall EH, Tarlow MJ, Flewett TH. Transmission of HBsAg from mother to infant in four ethnic groups. British Medical Journal 1978; 1: 949–952.
127. Zacharakis G, Koskinas J, Kotsiou S, et al. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece. Journal of Pediatric Gastroenterology and Nutrition 2007; 44: 84–91. DOI:10.1097/01.mpg.0000243438.47334.07 14600005176-200701000-00018 [pii].
128. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2: 1099–1102. DOI: 10.1002/hep.1840030201.
129. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 1983; 3: 135–141 DOI: 10.1002/hep.1840030201.
130. Marinier E, Barrois V, Larouze B, et al. Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. Journal of Pediatrics 1985; 106: 843–849.
131. Basalamah AH, Serebour F, Kazim E. Materno-foetal transmission of hepatitis B in Saudi Arabia. Journal of Infection 1984; 8: 200–204.
132. Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. American Journal of Medicine 2004; 116: 829–834. DOI:10.1016/j.amjmed.2003.12.040 S0002934304001469 [pii].
133. Chu CM, Liaw YF. Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. Journal of Hepatology 2005; 43: 411–417. DOI:10.1016/j.jhep.2005.03.018 S0168-8278(05)00308-9 [pii].
134. Chu CM, Liaw YF. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion. Journal of Viral Hepatitis 2007; 14: 147–152. DOI:10.1111/j.1365-2893.2006.00810.x JVH810 [pii].
135. Botha JF, Ritchie MJ, Dusheiko GM, Mouton HW, Kew MC. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet 1984; 1: 1210–1212.
136. Candotti D, Danso K, Allain JP. Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. The Journal of General Virology 2007; 88: 2686–2695. DOI:10.1099/vir.0.83102-0 88/10/2686 [pii].
137. Roingeard P, Diouf A, Sankale JL, et al. Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunology 1993; 6: 65–73.
138. Menendez C, Sanchez-Tapias JM, Kahigwa E, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. Journal of Medical Virology 1999; 58: 215–220. DOI: 10.1002/(SICI)1096-9071(199907)58:3<215::AID-JMV5>3.0.CO;2-K.
139. Acquaye JK, Mingle JA. Hepatitis B viral markers in Ghanaian pregnant women. West African Journal of Medicine 1994; 13: 134–137.
140. Tseng YR, Wu JF, Ni YH, et al. Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection. Liver International 2011; 31: 1373–1380. DOI:10.1111/j.1478-3231.2011.02574.x.
141. Cote PJ, Korba BE, Miller RH, et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 2000; 31: 190–200. DOI:10.1002/hep.510310128 S0270913900290794 [pii].
142. Hadziyannis SJ, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Research 2001; 52: 91–98. DOI:10.1016/S0166-3542(01)00173-5.
143. Hawkins AE, Gilson RJ, Beath SV, et al. Novel application of a point mutation assay: evidence for transmission of hepatitis B viruses with precore mutations and their detection in infants with fulminant hepatitis B. Journal of Medical Virology 1994; 44: 13–21.
144. Hessel L, West DJ. Antibody responses to recombinant hepatitis B vaccines. Vaccine 2002; 20: 2164–2165 DOI: 10.1016/S0264-410X(02)00117-2.
145. Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiologic Reviews 2006; 28: 126–135. DOI:10.1093/epirev/mxj010.
146. Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012; 142: 773–781 e772. DOI:10.1053/j.gastro.2011.12.035.
147. Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology; 142: 773–781 e772. DOI: 10.1053/j.gastro.2011.12.035 S0016-5085(11)01750-1 [pii]
148. Huang ML, Liao WL, Ho MS. HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure. Vaccine 2007; 25: 6326–6333. DOI:10.1016/j.vaccine.2007.06.022 S0264-410X(07)00699-8 [pii].
149. Liu CJ, Lo SC, Kao JH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. Journal of Hepatology 2006; 44: 39–46. DOI:10.1016/j.jhep.2005.06.016 S0168-8278(05)00449-6 [pii].
150. Lu CY, Chiang BL, Chi WK, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40: 1415–1420. DOI:10.1002/hep.20490.
151. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology 2008; 49: 652–657. DOI:10.1016/j.jhep.2008.07.014 S0168-8278(08)00479-0 [pii].
152. Gjorup IE, Skinhoj P, Bottiger B, Plesner AM. Changing epidemiology of HBV infection in Danish children. Journal of Infection 2003; 47: 231–235 S0163445303000707 [pii].
153. World Hepatitis Summit 2015. Glasgow, Scotland. 2–4 September. http://www.worldhepatitissummit.com/ [22 January 2016].